Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPP635 in Type 2 Diabetes with Hypertension and Albuminuria
NCT00561171Phase 2Completed
- Sponsor
- Speedel
- Start
- Nov 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of SPP 635 in hypertension (HTN) and albuminuria (2 arms), sponsored by Speedel. Primary endpoint: Ambulatory Blood Pressure Monitoring at 28 days. Started Nov 2007; status: completed.
02
Drugs
SPP 635
03
Conditions
hypertension (HTN)albuminuria
Beyond the preview
Go deeper on NCT00561171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00561171.